Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Berkell, Matilda"'
Autor:
Savoldi, Alessia, Morra, Matteo, De Nardo, Pasquale, Cattelan, Anna Maria, Mirandola, Massimo, Manfrin, Vinicio, Scotton, Piergiorgio, Giordani, Maria Teresa, Brollo, Lucio, Panese, Sandro, Lanzafame, Massimiliano, Scroccaro, Giovanna, Berkell, Matilda, Lippi, Giuseppe, Konnova, Angelina, Smet, Mathias, Malhotra-Kumar, Surbhi, Kumar-Singh, Samir, Tacconelli, Evelina, Canova, Marco, Rigo, Fabio, Coletto, Davide, Serino, Francesco Saverio, Coledan, Ilaria, Danese, Elisa, Peserico, Denise, Gelati, Matteo, Conti, Michela, Fasan, Daniele, Xavier, Basil Britto, Gupta, Akshita, Hotterbeekx, An, De Ambrosis, Paola
Publikováno v:
European journal of clinical microbiology and infectious diseases
This study aimed to compare the clinical progression of COVID-19 in high-risk outpatients treated with the monoclonal antibodies (mAb) bamlanivimab, bamlanivimab-etesevimab and casirivimab-imdevimab. This is an observational, multi-centre, prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1742d455c5bc02f813638a27eec463a
http://hdl.handle.net/11562/1068927
http://hdl.handle.net/11562/1068927
Autor:
Savoldi, Alessia, Morra, Matteo, Castelli, Alessandro, Mirandola, Massimo, Berkell, Matilda, Smet, Mathias, Konnova, Angelina, Rossi, Elisa, Cataudella, Salvatore, De Nardo, Pasquale, Gentilotti, Elisa, Gupta, Akshita, Fasan, Daniele, Gibbin, Enrico, Puviani, Filippo Cioli, Hasenauer, Jan, Gusinow, Roy, Tami, Adriana, Kumar-Singh, Samir, Malhotra-Kumar, Surbhi, mAb Orchestra Working Group, Null, Tacconelli, Evelina
Publikováno v:
Biomedicines
Biomedicines; Volume 10; Issue 9; Pages: 2063
Biomedicines, 10(9):2063. MDPI AG
Biomedicines 10:2063 (2022)
Biomedicines; Volume 10; Issue 9; Pages: 2063
Biomedicines, 10(9):2063. MDPI AG
Biomedicines 10:2063 (2022)
The clinical impact of anti-spike monoclonal antibodies (mAb) in Coronavirus Disease 2019 (COVID-19) breakthrough infections is unclear. We present the results of an observational prospective cohort study assessing and comparing COVID-19 progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c97446190b4b8834e698833eafd276
http://hdl.handle.net/11562/1074670
http://hdl.handle.net/11562/1074670
Autor:
Berkell, Matilda, Mysara, Mohamed, Xavier, Britto Basil, van Werkhoven, Cornelis H., Monsieurs, Pieter, Lammens, Christine, Ducher, Annie, Vehreschild, Maria J.G.T., Goossens, Herman, de Gunzburg, Jean, Bonten, Marc J. M., Malhotra, Surbhi, Ahmed, Mohamed Mysara, Engbers, Annemarie, de Regt, Marieke, Biehl, Lena M., Cornely, Oliver A., Jazmati, Nathalie, Bouverne, Marie-Noelle, Sablier-Gallis, Frederique, Mentre, France, Merle, Uta, Stallmach, Andreas, Rupp, Jan, Bogner, Johannes, Lubbert, Christoph, Silling, Gerda, Witzke, Oliver, Gikas, Achilleas, Maraki, Sofia, Daikos, George, Tsiodras, Sotirios, Skoutelis, Athanasios, Sambatakou, Helen, Pujol, Miguel, Dominguez-Luzon, M. Angeles, Aguado, Jose M., Bouza, Emilio, Cobo, Javier, Rodriguez-Bano, Jesus, Almirante, Benito, de la Cisneros, Julian Torre, Florescu, Simin A., Nica, Maria, Vata, Andrei, Hristea, Adriana, Lupse, Mihaela, Herghea, Delia, Postil, Deborah, Barraud, Olivier, Molina, Jean-Michel, De Lastours, Victoire, Guimard, Thomas, Talarmin, Jean-Philippe, Duval, Xavier, Bernard, Louis, Launay, Odile
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Nature communications
Nature Communications 12, 2241 (2021). doi:10.1038/s41467-021-22302-0
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Universidad de Barcelona
Nature communications
Nature Communications 12, 2241 (2021). doi:10.1038/s41467-021-22302-0
Nature Communications
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Antibiotic-induced modulation of the intestinal microbiota can lead to Clostridioides difficile infection (CDI), which is associated with considerable morbidity, mortality, and healthcare-costs globally. Therefore, identification of markers predictiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31581eff8291ed2ca591055cf71ef90c
Autor:
van Werkhoven, Cornelis H., Ducher, Annie, Berkell, Matilda, Mysara, Mohamed, Lammens, Christine, Torre-Cisneros, Julian, Rodríguez-Baño, Jesús, Herghea, Delia, Cornely, Oliver A., Biehl, Lena M., Bernard, Louis, Dominguez-Luzon, M. Angeles, Maraki, Sofia, Barraud, Olivier, Nica, Maria, Jazmati, Nathalie, Sablier-Gallis, Frederique, de Gunzburg, Jean, Mentré, France, Malhotra-Kumar, Surbhi, Bonten, Marc J. M., Vehreschild, Maria J. G. T., Engbers, Annemarie M. S., de Regt, Marieke J. A., Goossens, Herman, Xavier, Basil Britto, Bouverne, Marie-Noelle, Monsieurs, Pieter, Merle, Uta, Stallmach, Andreas, Rupp, Jan, Bogner, Johannes, Lübbert, Christoph, Silling, Gerda, Witzke, Oliver, Gikas, Achilleas, Daikos, George, Tsiodras, Sotirios, Skoutelis, Athanasios, Sambatakou, Helen, Pujol, Miquel, Aguado, Jose M., Bouza, Emilio, Cobo, Javier, Almirante, Benito, Florescu, Simin A., Vata, Andrei, Hristea, Adriana, Lupse, Mihaela, Postil, Deborah, Molina, Jean-Michel, De Lastours, Victoire, Guimard, Thomas, Talarmin, Jean-Philippe, Duval, Xavier, Launay, Odile
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
Nature communications
Dipòsit Digital de la UB
Universidad de Barcelona
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Nature Communications
instname
Nature communications
Dipòsit Digital de la UB
Universidad de Barcelona
Nature Communications, Vol 12, Iss 1, Pp 1-10 (2021)
Nature Communications
Trial enrichment using gut microbiota derived biomarkers by high-risk individuals can improve the feasibility of randomized controlled trials for prevention of Clostridioides difficile infection (CDI). Here, we report in a prospective observational c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2acae65093249b4533af205a3413b256
http://hdl.handle.net/10261/261889
http://hdl.handle.net/10261/261889
Autor:
Berkell, Matilda
Clostridioides difficile infection (CDI) is the most common form of infectious antibiotic-associated diarrhea (AAD) causing considerable morbidity and mortality in acute-care facilities. Hospitalized patients receiving broad-spectrum antibiotic treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2097::cb1892999446fefc21f65e8aa73d5d97
https://hdl.handle.net/10067/1689940151162165141
https://hdl.handle.net/10067/1689940151162165141
Autor:
Angelina Konnova, Fien H. R. De Winter, Akshita Gupta, Lise Verbruggen, An Hotterbeekx, Matilda Berkell, Laure-Anne Teuwen, Greetje Vanhoutte, Bart Peeters, Silke Raats, Isolde Van der Massen, Sven De Keersmaecker, Yana Debie, Manon Huizing, Pieter Pannus, Kristof Y. Neven, Kevin K. Ariën, Geert A. Martens, Marc Van Den Bulcke, Ella Roelant, Isabelle Desombere, Sébastien Anguille, Zwi Berneman, Maria E. Goossens, Herman Goossens, Surbhi Malhotra-Kumar, Evelina Tacconelli, Timon Vandamme, Marc Peeters, Peter van Dam, Samir Kumar-Singh
Publikováno v:
Frontiers in immunology
BackgroundPatients with cancer, especially hematological cancer, are at increased risk for breakthrough COVID-19 infection. So far, a predictive biomarker that can assess compromised vaccine-induced anti-SARS-CoV-2 immunity in cancer patients has not